Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-29

Clinical Trial Update: Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating targeted abdominal perfusion pressure for septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bozyaka Training and Research Hospital | Conditions: Septic Shock, Septicemia | Phase 4 | Status: COMPLETED